Dr. Adam Goldrich, MD
NPI: 1912292517
Total Payments
$660.07
2024 Payments
$288.50
Companies
18
Transactions
33
Medicare Patients
8,276
Medicare Billing
$5.6M
Payment Breakdown by Category
Food & Beverage$648.15 (98.2%)
Education$11.92 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $648.15 | 32 | 98.2% |
| Education | $11.92 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $91.08 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $79.68 | 4 | $0 (2020) |
| Celgene Corporation | $62.51 | 3 | $0 (2024) |
| ABBVIE INC. | $60.40 | 2 | $0 (2024) |
| Amgen Inc. | $46.35 | 2 | $0 (2023) |
| SERVIER PHARMACEUTICALS LLC | $38.34 | 2 | $0 (2024) |
| Lilly USA, LLC | $36.75 | 2 | $0 (2019) |
| Janssen Biotech, Inc. | $35.19 | 2 | $0 (2019) |
| Invivyd Inc | $35.07 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $30.77 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $288.50 | 12 | PFIZER INC. ($73.14) |
| 2023 | $46.35 | 2 | Amgen Inc. ($46.35) |
| 2022 | $15.71 | 1 | E.R. Squibb & Sons, L.L.C. ($15.71) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2020 | $54.65 | 3 | Novartis Pharmaceuticals Corporation ($22.50) |
| 2019 | $226.66 | 13 | Novartis Pharmaceuticals Corporation ($57.18) |
| 2018 | $16.28 | 1 | Genentech USA, Inc. ($16.28) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $20.49 | General |
| 10/09/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $32.27 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Invivyd Inc | PEMGARDA (Biological) | Food and Beverage | In-kind items and services | $35.07 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/26/2024 | SERVIER PHARMACEUTICALS LLC | Voranigo (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Oncology | ||||||
| 08/22/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Oncology | ||||||
| 08/14/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $21.23 | General |
| Category: Hematology | ||||||
| 06/19/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: General - Therapies_CRM | ||||||
| 05/14/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $20.79 | General |
| Category: Hematology | ||||||
| 04/15/2024 | PFIZER INC. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: Oncology | ||||||
| 04/09/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: HEMATOLOGY | ||||||
| 03/19/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: ONCOLOGY | ||||||
| 04/12/2023 | Amgen Inc. | Blincyto (Biological), Kyprolis | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Oncology | ||||||
| 03/30/2023 | Amgen Inc. | Blincyto (Biological), Kyprolis | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Oncology | ||||||
| 03/21/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.71 | General |
| Category: Cardiovascular | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 02/20/2020 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: ONCOLOGY | ||||||
| 01/23/2020 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: ONCOLOGY | ||||||
| 01/08/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $17.13 | General |
| Category: Oncology | ||||||
| 11/06/2019 | Merck Sharp & Dohme Corporation | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2019 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Oncology | ||||||
| 10/18/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $14.94 | General |
| 09/19/2019 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Oncology | ||||||
| 08/19/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.70 | General |
| 07/10/2019 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 53 | 2,341 | 77,264 | $6.9M | $1.9M |
| 2022 | 55 | 2,571 | 100,266 | $7.1M | $1.7M |
| 2021 | 51 | 2,230 | 85,242 | $5.9M | $1.5M |
| 2020 | 23 | 1,134 | 16,870 | $1.1M | $458,393 |
Total Patients
8,276
Total Services
279,642
Medicare Billing
$5.6M
Procedure Codes
188
All Medicare Procedures & Services
188 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 24 | 26,800 | $3.4M | $1.2M | 34.2% |
| J9299 | Injection, nivolumab, 1 mg | Office | 2023 | 12 | 16,680 | $1.2M | $394,967 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 353 | 985 | $217,947 | $68,890 | 31.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 92 | 442 | $303,212 | $47,824 | 15.8% |
| Q5122 | Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | Office | 2023 | 14 | 468 | $411,372 | $46,305 | 11.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 127 | 275 | $84,224 | $28,148 | 33.4% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2023 | 34 | 20,670 | $186,030 | $27,951 | 15.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 215 | 1,040 | $64,480 | $10,755 | 16.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 227 | 1,153 | $40,355 | $8,724 | 21.6% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 55 | 332 | $50,464 | $7,971 | 15.8% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 32 | 138 | $46,092 | $7,497 | 16.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 40 | 40 | $21,821 | $7,064 | 32.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 52 | 462 | $48,510 | $5,932 | 12.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $19,188 | $5,351 | 27.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 52 | 102 | $31,008 | $5,325 | 17.2% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 12 | 75 | $15,375 | $4,629 | 30.1% |
| 96411 | Administration of additional new drug or substance into vein using push technique | Office | 2023 | 15 | 95 | $26,695 | $4,375 | 16.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 26 | $10,468 | $3,871 | 37.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 20 | 107 | $16,692 | $2,575 | 15.4% |
| 96409 | Administration of chemotherapy into vein using push technique | Office | 2023 | 11 | 27 | $13,095 | $2,346 | 17.9% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 35 | 357 | $164,934 | $2,330 | 1.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $5,501 | $1,678 | 30.5% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2023 | 40 | 1,930 | $235,460 | $1,585 | 0.7% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 31 | 171 | $9,234 | $1,558 | 16.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 46 | 129 | $11,709 | $1,484 | 12.7% |
About Dr. Adam Goldrich, MD
Dr. Adam Goldrich, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Annapolis, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2011. The National Provider Identifier (NPI) number assigned to this provider is 1912292517.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Goldrich, MD has received a total of $660.07 in payments from pharmaceutical and medical device companies, with $288.50 received in 2024. These payments were reported across 33 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($648.15).
As a Medicare-enrolled provider, Goldrich has provided services to 8,276 Medicare beneficiaries, totaling 279,642 services with total Medicare billing of $5.6M. Data is available for 4 years (2020–2023), covering 188 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Hematology & Oncology
- Location Annapolis, MD
- Active Since 06/13/2011
- Last Updated 07/25/2018
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1912292517
Products in Payments
- ELAHERE (Drug) $60.40
- Blincyto (Biological) $46.35
- REBLOZYL (Biological) $42.02
- PROMACTA (Drug) $40.82
- VERZENIO (Drug) $36.75
- PEMGARDA (Biological) $35.07
- ELIQUIS (Drug) $30.77
- TUKYSA (Drug) $27.47
- IBRANCE (Drug) $25.01
- GILOTRIF (Drug) $23.38
- IMBRUVICA (Drug) $20.98
- OXBRYTA (Drug) $20.66
- Voranigo (Drug) $19.57
- Tibsovo (Drug) $18.77
- CHANTIX (Drug) $17.94
- Lenvima (Drug) $17.13
- Avastin (Biological) $16.28
- ZEJULA (Drug) $15.02
- ADCETRIS (Biological) $14.81
- DARZALEX (Biological) $14.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Annapolis
Dr. Igor Belyansky, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $645,870
Student in an Organized Health Care Education/Training Program $645,870
Juddson Chason, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $20,881
Student in an Organized Health Care Education/Training Program $20,881
Mary Holthaus, Pa, PA
Student in an Organized Health Care Education/Training Program — Payments: $11,376
Student in an Organized Health Care Education/Training Program $11,376
Samip Patel, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $10,231
Student in an Organized Health Care Education/Training Program $10,231
Kari Bailey, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $6,236
Student in an Organized Health Care Education/Training Program $6,236
Sadia Shafi
Student in an Organized Health Care Education/Training Program — Payments: $4,764
Student in an Organized Health Care Education/Training Program $4,764